Know Cancer

or
forgot password

    • cancer clinical trials in idaho

    • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Hematology Oncology Associates of Eastern Idaho
    Idaho Falls, Idaho 83404
    Breast Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    St. Luke's Regional Medical Center
    Boise, Idaho 83712
    Breast Cancer
    Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    Kootenai Cancer Center
    Post Falls, Idaho 83854
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    St. Luke's Mountain States Tumor Institute - Boise

    Trial Locations
    St. Luke's Mountain States Tumor Institute - Boise
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Lymphoma
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    St. Luke's Mountain States Tumor Institute - Boise

    Trial Locations
    St. Luke's Mountain States Tumor Institute - Boise
    Hematology Oncology Associates of Eastern Idaho
    Breast Cancer
    STI571 in Treating Patients With Recurrent Leukemia
    Mountain States Tumor Institute
    Boise, Idaho 83712
    Leukemia
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Mountain States Tumor Institute
    Boise, Idaho 83712
    Brain and Central Nervous System Tumors
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Lymphoma
    Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
    Mountain States Tumor Institute - Boise
    Boise, Idaho 83712
    Multiple Myeloma and Plasma Cell Neoplasm
    Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Sarcoma
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Prostate Cancer
    Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    St. Luke's Mountain States Tumor Institute - Boise
    Boise, Idaho 83712-6297
    Multiple Myeloma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Breast Cancer
    R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
    North Idaho Urology
    Couer D'Alene, Idaho 83814
    Prostate Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Esophageal Cancer, Gastric Cancer
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    St. Luke's Mountain States Tumor Institute - Boise

    Trial Locations
    St. Luke's Mountain States Tumor Institute - Boise
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Hematology Oncology Associates of Eastern Idaho
    Portneuf Cancer Center at Portneuf Medical Center
    Breast Cancer
    S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Multiple Myeloma, Plasma Cell Myeloma
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Saint Luke's Mountain States Tumor Institute

    Trial Locations
    Saint Luke's Mountain States Tumor Institute
    Kootenai Cancer Center
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center

    Trial Locations
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Kootenai Cancer Center - Coeur d'Alene
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Portneuf Cancer Center at Portneuf Medical Center
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Saint Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Brain Tumor, Central Nervous System Tumor
    PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    St. Luke's Mountain States Tumor Institute

    Trial Locations
    St. Luke's Mountain States Tumor Institute
    North Idaho Cancer Center
    Pancreatic Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Trial Locations
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Kootenai Cancer Center - Coeur d'Alene
    Breast Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Saint Alphonsus Regional Medical Center
    Boise, Idaho 83706
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Multiple Myeloma and Plasma Cell Neoplasm
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    St Luke's Mountain States Tumor Institute
    Boise, Idaho 83712
    Chronic Lymphocytic Leukemia
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Mountain States Tumor Institute at St. Luke's Regional Medical Center
    Boise, Idaho 83712-6297
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Luke's Mountain States Tumor Institute

    Trial Locations
    Saint Luke's Mountain States Tumor Institute
    Portneuf Medical Center
    Kootenai Cancer Center
    Adenocarcinoma of the Colon, Stage II Colon Cancer